Dean’s Inaugural Symposium On Opportunities for Entrepreneurship and Academic Drug Development

Augustine M.K. Choi, M.D.

invites you to the

Dean’s Inaugural Symposium
On Opportunities for
Entrepreneurship and Academic Drug Development

 

Featuring a keynote address by Kenneth Frazier, Chairman and CEO of Merck, and presentations on the Tri-I TDI, Bridge Medicines, Center for Technology Licensing, and Office of BioPharma Alliances and Research Collaborations.

 

Monday, October 9, 2017
2 p.m. – 4 p.m.

Uris Auditorium, Meyer Building, 1300 York Avenue
Reception to follow in Griffis Faculty Club, 4 p.m. – 5 p.m.

 

Please RSVP to sng3001@med.cornell.edu or (646) 962-9478.

The symposium will be recorded and available to individuals on WCM Central.

 

------

AGENDA

2 p.m.  Welcome

Augustine M.K. Choi, M.D., Stephen and Suzanne Weiss Dean, Weill Cornell Medicine

2:15 p.m. Pharmaceutical Product Development: The Case for Investing in Invention

Kenneth C. Frazier, Chairman of the Board and CEO, Merck & Co., Inc.

2:40 p.m. Tri-I TDI: Transforming Academic Drug Discovery and Development

Michael A. Foley, Ph.D., Sanders Director of the Tri-Institutional Therapeutics Drug Discovery Institute

2:50 p.m. Therapeutic Targeting of Sphingolipid Signaling in Preclinical Models of Stroke: The Critical Role of the Tri-I TDI

Teresa Sanchez, Ph.D., Assistant Professor of Pathology and Laboratory Medicine

3 p.m. Bridge Medicines: Industry Expertise for Bridging the Gap to Clinical Studies

William J. Polvino, M.D., Chief Executive Officer, Bridge Medicines

3:10 p.m. Commercializing Technology with CTL: What’s in it for You?

Brian J. Kelly, Ph.D., Director, Technology Licensing, WCM Office of the Center for Technology Licensing

3:20 p.m. BioPharma Alliances and Research Collaborations: Building Value Around Early Stage Discovery Research through Dedicated Alliances with Industry

Larry Schlossman, Managing Director, BioPharma Alliances and Research Collaborations                                           

3:30 p.m. The Critical Importance of BioPharma Alliances in Support of Early Stage Translational Research     

Timothy E. McGraw, Ph.D., Professor of Biochemistry and of Biochemistry in Cardiothoracic Surgery

3:40 p.m. Q&A

Moderated by Dr. Augustine M.K. Choi

4 p.m. Conclusion

Reception to follow in Griffis Faculty Club

Monday, October 9 at 2:00pm to 5:00pm

Uris Auditorium
1300 York Ave., New York NY 10065

Event Type

Conference, Lecture/Seminar, Party/Reception, Translational Lecture/Seminar, Information Session, Symposium

Departments

Office of the Dean, Meyer Cancer Center

Mission

Research

Subscribe
Google Calendar iCal Outlook

Recent Activity